Cite
HARVARD Citation
Smolen, J. et al. (n.d.). 060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate. Rheumatology. p. . [Online].